v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents [note 3 and note 6] $ 20,929 $ 12,753
Marketable securities [note 6] 15,475 21,607
Total current assets 39,889 36,467
Restricted cash and other assets [note 6 and note 7] 52 39
Right-of-use assets [note 12] 64 119
License agreement [note 4 and note 5] 751 974
Goodwill 1,034 1,034
Total assets 41,790 38,633
Current liabilities:    
Accrued clinical liabilities 368 1,077
Accrued compensation 1,921 3,027
Current contingent consideration [note 5 and note 6] 1,557 0
Current portion of long-term obligations [note 12] 61 55
Current portion of convertible debt [note 6 and note 8] 3,704  
Total current liabilities 9,082 6,682
Non-current portion of convertible debt [note 6 and note 8] 11,185 9,837
Non-current contingent consideration [note 5 and note 6] 0 1,149
Long-term obligations [note 12] 5 66
Total liabilities 20,272 17,734
Commitments and contingencies [note 12]
Stockholders' equity:    
Common stock, $0.001 par value, 150,000,000 shares authorized, 53,233,988 and 34,685,072 issued and outstanding at December 31, 2025 and December 31, 2024, respectively. 121 103
Additional paid-in capital 281,613 226,343
Accumulated deficit (260,226) (205,578)
Accumulated other comprehensive income 10 31
Total stockholders' equity 21,518 20,899
Total liabilities and stockholders' equity 41,790 38,633
Series A Convertible Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock, value
Series B Convertible Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock, value
Nonrelated Party [Member]    
Current assets:    
Prepaid expenses and other assets 3,292 2,107
Current liabilities:    
Accounts payable 859 1,950
Accrued liabilities other 598 $ 573
Related Parties [Member]    
Current assets:    
Prepaid expenses and other assets 193  
Current liabilities:    
Accounts payable 8  
Accrued liabilities other $ 6